Immune checkpoint combos in metastatic castration-resistant prostate cancer: Where are we going, what are we doing, and why? Editorial

  


Author: Slovin, S. F.
Title: Immune checkpoint combos in metastatic castration-resistant prostate cancer: Where are we going, what are we doing, and why?
Keywords: editorial; prostate; drug therapy; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); immune checkpoint inhibitor; human; male; metastatic castration resistant prostate cancer
Journal Title: Journal of Clinical Oncology
Volume: 43
Issue: 14
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2025-05-10
Start Page: 1617
End Page: 1619
Language: English
DOI: 10.1200/jco-24-02402
PUBMED: 40080739
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-105000268684&doi=10.1200%2fJCO-24-02402&partnerID=40&md5=eb7337fcf6eee1e92aa4313abc131746
Notes: Editorial -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Susan Slovin
    254 Slovin
Related MSK Work